Tenax Therapeutics
(TENX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 07-2011 | 04-2011 | 01-2011 | 10-2010 | 07-2010 | |
| Sales | 60 | 0 | 53 | 36 | 7 |
| Cost of Goods | 35 | N/A | 26 | 9 | 2 |
| Gross Profit | 25 | N/A | 27 | 27 | 5 |
| Operating Expenses | 2,488 | 0 | 2,807 | 2,093 | 3,030 |
| Operating Income | -2,428 | N/A | -2,755 | -2,057 | -3,023 |
| Interest Expense | 436 | 0 | 43 | 5 | 1 |
| Other Income | -5 | 0 | 254 | 10 | 22 |
| Pre-tax Income | -2,869 | 0 | -2,544 | -2,052 | -3,002 |
| Net Income Continuous | -2,869 | N/A | -2,544 | -2,052 | -3,002 |
| Net Income | $-2,869 | $N/A | $-2,544 | $-2,052 | $-3,002 |
| EPS Basic Total Ops | -0.12 | N/A | -0.11 | -0.09 | -0.13 |
| EPS Basic Continuous Ops | -0.12 | N/A | -0.11 | -0.09 | -0.13 |
| EPS Diluted Total Ops | -0.33 | N/A | -0.11 | -0.09 | -0.13 |
| EPS Diluted Continuous Ops | -0.12 | N/A | -0.11 | -0.09 | -0.13 |
| EBITDA(a) | $-2,428 | $N/A | $-1,340 | $-1,866 | $-3,023 |